|Articles|November 18, 2022
- Pharm Exec E-Books-11-18-2022
- Volume Sponsored eBook
- Issue 6
Investing in Next-Generation Tokenization and Real-World Data to Unlock a More Precise and Complete Patient Journey
Author(s)LexisNexis® Risk Solutions
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Related Content
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
How Will MFN’s Effects on Medicare Impact Innovation?
5